National Comprehensive Cancer Network



About NCCN

Prostate Cancer Panel - Disclosures as of 5/23/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Andrew J. Armstrong, MD, ScM

Active Biotech AB;
Bristol-Myers Squibb Company;
Dendreon Corporation;
ImClone Systems Incorporated;
Johnson & Johnson;
Novartis Pharmaceuticals Corporation;
Kanglaite;
Medivation;
Pfizer Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Dendreon Corporation;
Johnson & Johnson;
Ipsen;
sanofi-aventis U.S.

None

None

5/2/2014

Robert R. Bahnson, MD

None

Aveo Pharmaceuticals;
Young,Ricchiuti,Caldwell, and Heller,LLC

None

None

6/9/2014

Michael Cohen, MD

None

LivingstonBarger;
Otorowski, et al.;
Simmons Perrine et al.

None

None

6/26/2013

Anthony Victor D'Amico, MD, PhD

None

None

None

None

4/9/2014

James A. Eastham, MD

None

None

None

None

5/21/2014

Charles A. Enke, MD

None

Myriad Genetic Laboratories, Inc.

None

None

6/4/2014

Thomas A. Farrington, BSEE

None

None

None

None

6/3/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Celestia S. Higano, MD, FACP

None

Amgen Inc.;
Bayer HealthCare;
Dendreon Corporation;
Millennium Pharmaceuticals, Inc.

None

Medivation

6/9/2014

Maria Ho, PhD

None

None

None

None

7/10/2014

Eric Mark Horwitz, MD

None

None

None

None

6/6/2014

Philip W. Kantoff, MD

None

Bayer HealthCare;
Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
Bavarian Nordic Immunotherapy (BN-IT);
Tokai

None

None

4/15/2014

Mark H. Kawachi, MD

None

None

None

None

6/4/2014

Michael Kuettel, MD, MBA, PhD

None

None

None

None

5/21/2014

Richard J. Lee, MD, PhD

None

None

None

None

6/4/2014

Gary R. MacVicar, MD

None

Amgen Inc.;
Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
Medivation

None

None

1/28/2013

Arnold W. Malcolm, MD, FACR

None

None

None

None

5/23/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

David Miller, MD, MPH

Blue Cross Blue Shield of Michigan

UnitedHealthcare

None

None

10/10/2012

James L. Mohler, MD

Roswell Park Cancer Institute

None

None

Androbiosys, Inc.

5/2/2014

Elizabeth R. Plimack, MD, MS

None

Amgen Inc.

None

None

5/7/2014

Julio M. Pow-Sang, MD

None

Myriad Genetic Laboratories, Inc.

None

None

5/23/2014

Sylvia Richey, MD

None

Astellas / Medivation Speaker

None

None

9/17/2014

Mack Roach III, MD

None

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
;
ARISTA;
Astellas;
Ferring Pharma

None

None

6/6/2014

Eric Rohren, MD, PhD

None

None

None

None

5/13/2014

Stan Rosenfeld

None

None

None

None

9/16/2014

Dorothy Shead, MS

None

None

None

None

8/7/2014

Eric J. Small, MD

None

Dendreon Corporation

None

None

6/9/2014

Guru Sonpavde, MD

None

Amgen Inc.;
Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

12/19/2013

Sandy Srinivas, MD

Medivation

Medivation

None

None

12/9/2013

Cy Stein, MD, PhD

None

Amgen Inc.;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

3/28/2014

Seth A. Strope, MD, MPH

None

None

None

None

6/2/2014

Jonathan Tward, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

6/9/2014

Patrick C. Walsh, MD

None

None

None

None

7/31/2012